Roles of aminoacyl-tRNA synthetases in immune regulation and immune diseases

A Nie, B Sun, Z Fu, D Yu - Cell death & disease, 2019 - nature.com
Aminoacyl-tRNA synthetases (ARSs) play a vital role in protein synthesis by linking amino
acids to their cognate transfer RNAs (tRNAs). This typical function has been well recognized …

Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: an up-to-date review

G Bouz, J Zitko - Bioorganic chemistry, 2021 - Elsevier
Aminoacyl-tRNA synthetases (aaRSs) are crucial for the correct assembly of amino acids to
cognate tRNA to maintain the fidelity of proteosynthesis. AaRSs have become a hot target in …

Drug Discovery for Mycobacterium tuberculosis Using Structure-Based Computer-Aided Drug Design Approach

MA Ejalonibu, SA Ogundare, AA Elrashedy… - International Journal of …, 2021 - mdpi.com
Developing new, more effective antibiotics against resistant Mycobacterium tuberculosis that
inhibit its essential proteins is an appealing strategy for combating the global tuberculosis …

Synthesis, antimicrobial and antioxidant evaluation with in silico studies of new thiazole Schiff base derivatives

MS Shah, MM Rahman, MD Islam, A Al-Macktuf… - Journal of Molecular …, 2022 - Elsevier
A series of nineteen thiazole Schiff base derivatives 2a-2s were synthesized (Scheme 1)
and elucidated by spectral analyses (IR, 1 H NMR and HRMS). The evaluation of their …

Opportunities for overcoming tuberculosis: Emerging targets and their inhibitors

L Yang, X Hu, X Chai, Q Ye, J Pang, D Li, T Hou - Drug Discovery Today, 2022 - Elsevier
Tuberculosis (TB), an airborne infectious disease mainly caused by Mycobacterium
tuberculosis (Mtb), remains a leading cause of human morbidity and mortality worldwide …

Serum sCD14, PGLYRP2 and FGA as potential biomarkers for multidrug‐resistant tuberculosis based on data‐independent acquisition and targeted proteomics

J Chen, YS Han, WJ Yi, H Huang, ZB Li… - Journal of Cellular …, 2020 - Wiley Online Library
Multidrug‐resistant tuberculosis (MDR‐TB), defined as tuberculosis (TB) resistant to at least
isoniazid and rifampicin, is a major concern of TB control worldwide. However, the diagnosis …

Recent development of leucyl-tRNA synthetase inhibitors as antimicrobial agents

P Zhang, S Ma - Medchemcomm, 2019 - pubs.rsc.org
Aminoacyl-tRNA synthetases (aaRSs) widely exist in organisms and mediate protein
synthesis. Inhibiting these synthetases can lead to the termination of protein synthesis and …

Laboratory Evolution of Antimicrobial Resistance in Bacteria to Develop Rational Treatment Strategies

T Maeda, C Furusawa - Antibiotics, 2024 - mdpi.com
Laboratory evolution studies, particularly with Escherichia coli, have yielded invaluable
insights into the mechanisms of antimicrobial resistance (AMR). Recent investigations have …

New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease

SFK Lee, BE Laughon, TD McHugh… - Current Opinion in …, 2019 - journals.lww.com
New drugs to treat difficult tuberculous and nontuberculous... : Current Opinion in
Pulmonary Medicine New drugs to treat difficult tuberculous and nontuberculous …

Crystal structure, DFT calculation, molecular docking, in vitro biological activity evaluation and in silico drug-likeness prediction of (E)-N-(4-bromophenyl)-4-(2-(2 …

T Liu, J Chen, C Fan, C Wu, T Sun - Journal of Molecular Structure, 2023 - Elsevier
Abstract Herein, a novel Mtb LeuRS inhibitor compound 1A was synthesized and
crystallized. And compound 1A was found to be active targeting Mtb LeuRS with IC 50 …